Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound ...
admin
The new presentation expands the European availability of Samsung Bioepis’ aflibercept biosimilar following the launch of its vial format ...
The company said the high-dose group showed a statistically significant improvement in 90-day functional outcomes, but detailed efficacy ...
Data presented at AAIC 2026 support further evaluation of a once-weekly 500 mg autoinjector regimen as an alternative to intravenous ...
The transaction will make Gennova a wholly owned subsidiary of Emcure as the biopharma business shifts its focus towards biologics, ...
The collaboration will see OneSource provide integrated biologics manufacturing services for Formycon’s global biosimilar pipeline from ...
July has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Aledade, Providence and Whoop named new executives. ...
Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to ...
A Kura Oncology and Kyowa Kirin-partnered drug vying to become the first FDA-approved treatment for cases of acute myeloid leukemia (AML) carrying ...
